loading...| Preferred Name |
arbekacin |
| Synonyms |
arbekacin sulfate |
| ID |
http://purl.bioontology.org/ontology/MESH/C031986 |
| altLabel |
arbekacin sulfate Butanamide, 4-amino-N-((1R,2S,3S,4R,5S)-5-amino-2-((3-amino-3-deoxy-alpha-D-glucopyranosyl)oxy)-4-((2,6-diamino-2,3,4,6-tetradeoxy-alpha-D-erythro-hexopyranosyl)oxy)-3-hydroxycyclohexyl)-2-hydroxy-, (2S)- habekacin 1-N-((S)-4-amino-2-hydroxybutyryl)dibekacin 4-amino-2-hydroxybutylyldibekacin ME1100 |
| cui |
C5392763 C0772381 C4082272 C0062073 |
| Has mapping qualifier | |
| HM |
D003982/Q000031 |
| Inverse of RB |
G7V6SLI20L G7395HZ992 |
| isa | |
| LT |
TRD |
| Mapped to | |
| MDA |
19811125 |
| MeSH Frequency |
250 |
| MMR |
20210924 |
| notation |
C031986 |
| PA |
D000900 |
| PI |
*AMINOGLYCOSIDES (1981-2008) |
| prefLabel |
arbekacin |
| RR |
104931-87-5 (arbekacin sulfate) G7395HZ992 51025-85-5 (arbekacin) |
| SC |
1 |
| Scope Statement |
structure given in first source |
| SRC |
J Antibiot (Tokyo) 1981;34(7):892 |
| TERMUI |
T001083262 T493720 T130126 T130127 T130129 T130128 |
| TH |
FDA SRS (2013) FDA SRS (2017) NLM (2002) NLM (1981) INN (19XX) NLM (2020) |
| tui |
T109 T195 |